in vitro News and Research

RSS

New findings show combination of statins and omega-3 fatty acid may potentially reduce cardiovascular risk

New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.

2 May 2014

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Teva Pharmaceutical Industries Ltd. today announced positive results from a pivotal Phase III study of hydrocodone bitartrate extended-release tablets designed with Teva's proprietary technology providing potential abuse-deterrent properties (CEP-33237).

30 Apr 2014

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Purdue Pharma L.P. announced that it has filed a New Drug Application (NDA) with the U.S. Food & Drug Administration seeking authorization to market a once-daily, single-entity hydrocodone bitartrate tablet (HYD).

30 Apr 2014

Cutting-edge EmbryoScope technology now available to couples seeking fertility treatment in Florida

The latest in cutting-edge technology, The EmbryoScope, is now available to couples seeking fertility treatment in Florida at IVF FLORIDA Reproductive Associates.

30 Apr 2014

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Otsuka Pharmaceutical Co., Ltd. today announced that the European Commission has granted a marketing authorization for Deltyba (delamanid) for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.

30 Apr 2014

Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos

Illumina, Inc. today announced the launch of VeriSeq PGS, a next-generation sequencing solution developed for preimplantation genetic screening of embryos using Illumina's NextSeq 500 and MiSeq® sequencing systems.

From Illumina, Inc. 29 Apr 2014

Engineering breakthrough allows cancer researchers to create living tumors

Drexel's Wei Sun, PhD, Albert Soffa chair professor in the College of Engineering, has devised a method for 3D printing tumors that could soon be taking cancer research out of the petri dish.

26 Apr 2014

Cook Medical launches Stemulate Pooled Human Platelet Lysate cell culture media supplement

Cook Medical will introduce its Stemulate Pooled Human Platelet Lysate cell culture media supplement at the 2014 International Society for Cellular Therapy meeting, April 23-26.

From COOK MEDICAL INC. 25 Apr 2014

NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid Cleanser.

23 Apr 2014

RMANJ releases new fertility checklist for early diagnosis and treatment options

With over seven million men and women in the United States impacted by infertility, information about early diagnosis and various infertility treatment options like in vitro fertilization (IVF), preimplantation genetic diagnosis (PGD), and comprehensive chromosome screening (CCS) can offer help to many patients looking to overcome infertility.

22 Apr 2014

New hypothesis about emergence of Parkinson's disease

The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells.

21 Apr 2014

Blog explains why NeutroPhase can play important role in treating 'flesh-eating' infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay's NeutroPhase wound cleanser in a recent blog posting. The blog explains why NeutroPhase can play an important role in treating life-threatening necrotizing fasciitis, or 'flesh-eating' infections.

21 Apr 2014

Stanford researchers identify normal cell type that gives rise to most invasive bladder cancers

A single type of cell in the lining of the bladder is responsible for most cases of invasive bladder cancer, according to researchers at the Stanford University School of Medicine.

21 Apr 2014

Financial pressures lead patients, doctors to choose fertility treatments that raise risk of premature birth

While it is well known that fertility treatments are the leading cause of increases in multiple gestations and that multiples are at elevated risk of premature birth, these results are not inevitable, concludes an article in Fertility and Sterility.

17 Apr 2014

IVF prevents multiple births in patients undergoing fertility treatments

While fertility treatments have helped many people become parents, they commonly result in multiple births, increasing the risk of prematurity, and leading to lifelong complications.

17 Apr 2014

Researchers identify new Chinese herbal medicine that inhibits hepatitis C virus activity

Data from a late-breaking abstract presented at the International Liver CongressTM 2014 identifies a new compound, SBEL1, that has the ability to inhibit hepatitis C virus (HCV) activity in cells at several points in the virus' lifecycle.

15 Apr 2014

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that the FDA has granted clearance to proceed with VLX600 into the clinical phase I/II. VLX600 is one of the company's promising projects, and which was recently published in the journal Nature Communications.

15 Apr 2014

Domain Therapeutics receives grant to support development of mGluR3 PAM for Parkinson’s disease

Domain Therapeutics, a biopharmaceutical company specializing in the research and development of new drug candidates targeting G protein-coupled receptors (GPCRs), today announces the receipt of a second grant of 230 000 dollars (USD) from The Michael J. Fox Foundation for Parkinson’s Research to support its metabotropic glutamate receptor type III (mGluR3) positive allosteric modulators (PAM) program.

15 Apr 2014

New data shows that gut microbiota has potential role in development of ALD

Exciting new data presented today at the International Liver Congress- 2014 shows that the gut microbiota has a potential role in the development of alcoholic liver disease (ALD).

15 Apr 2014

Researchers identify eight new active molecules against Alzheimer

Researchers of the Unit of Medicine Design and Molecular Topology (Department of Physics Chemistry) of the University of Valencia have discovered eight new active molecules against Alzheimer by a novel mechanism of action, different to the currently used medicines. The work has just been published in the "Plos One" magazine.

11 Apr 2014

in vitro News and Research

New findings show combination of statins and omega-3 fatty acid may potentially reduce cardiovascular risk

Teva announces positive results from pivotal Phase III study of hydrocodone bitartrate extended-release tablets

Purdue Pharma seeks FDA authorization to market once-daily hydrocodone bitartrate tablet

Cutting-edge EmbryoScope technology now available to couples seeking fertility treatment in Florida

Otsuka's Deltyba gets EC marketing authorization for MDR-TB treatment

Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos

Engineering breakthrough allows cancer researchers to create living tumors

Cook Medical launches Stemulate Pooled Human Platelet Lysate cell culture media supplement

NovaBay introduces new eye care product to help patients with eyelids irritation

RMANJ releases new fertility checklist for early diagnosis and treatment options

New hypothesis about emergence of Parkinson's disease

Blog explains why NeutroPhase can play important role in treating 'flesh-eating' infections

Stanford researchers identify normal cell type that gives rise to most invasive bladder cancers

Financial pressures lead patients, doctors to choose fertility treatments that raise risk of premature birth

IVF prevents multiple births in patients undergoing fertility treatments

Researchers identify new Chinese herbal medicine that inhibits hepatitis C virus activity

Vivolux receives FDA clearance to proceed with phase I/II clinical trial of VLX600

Domain Therapeutics receives grant to support development of mGluR3 PAM for Parkinson’s disease

New data shows that gut microbiota has potential role in development of ALD

Researchers identify eight new active molecules against Alzheimer

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News